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Abstract
During blastocyst formation the segregation of the inner cell mass (ICM) and trophectoderm is governed by the mutually
antagonistic effects of the transcription factors Oct4 and Cdx2. Evidence indicates that suppression of Oct4 expression in
the trophectoderm is mediated by Cdx2. Nonetheless, the underlying epigenetic modifiers required for Cdx2-dependent
repression of Oct4 are largely unknown. Here we show that the chromatin remodeling protein Brg1 is required for Cdx2-
mediated repression of Oct4 expression in mouse blastocysts. By employing a combination of RNA interference (RNAi) and
gene expression analysis we found that both Brg1 Knockdown (KD) and Cdx2 KD blastocysts exhibit widespread expression
of Oct4 in the trophectoderm. Interestingly, in Brg1 KD blastocysts and Cdx2 KD blastocysts, the expression of Cdx2 and
Brg1 is unchanged, respectively. To address whether Brg1 cooperates with Cdx2 to repress Oct4 transcription in the
developing trophectoderm, we utilized preimplantation embryos, trophoblast stem (TS) cells and Cdx2-inducible embryonic
stem (ES) cells as model systems. We found that: (1) combined knockdown (KD) of Brg1 and Cdx2 levels in blastocysts
resulted in increased levels of Oct4 transcripts compared to KD of Brg1 or Cdx2 alone, (2) endogenous Brg1 co-
immunoprecipitated with Cdx2 in TS cell extracts, (3) in blastocysts Brg1 and Cdx2 co-localize in trophectoderm nuclei and
(4) in Cdx2-induced ES cells Brg1 and Cdx2 are recruited to the Oct4 promoter. Lastly, to determine how Brg1 may induce
epigenetic silencing of the Oct4 gene, we evaluated CpG methylation at the Oct4 promoter in the trophectoderm of Brg1
KD blastocysts. This analysis revealed that Brg1-dependent repression of Oct4 expression is independent of DNA
methylation at the blastocyst stage. In toto, these results demonstrate that Brg1 cooperates with Cdx2 to repress Oct4
expression in the developing trophectoderm to ensure normal development.
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Introduction
The first cell-fate decision in the preimplantation embryo, the
differentiation of the ICM and trophectoderm, is regulated by the
transcription factors Oct4 and Cdx2. Initially, both Oct4 and Cdx2
are widely expressed. However, during blastocyst formation Oct4
expressionisrestrictedtotheICMandCdx2expressionisconfinedto
the trophectoderm [1,2]. Evidence indicates that suppression of Oct4
in the trophectoderm is mediated by the inhibitory actions of Cdx2.
For example, loss of Cdx2 in early mouse embryos results in
developmental arrest around the blastocyst stage and widespread
expression of Oct4 in the trophectoderm [2]. Furthermore, forced
expression of Cdx2 in embryonic stem (ES) cells induces Oct4
repression via Cdx2 binding to the autoregulatory element (ARE) in
the Oct4 promoter resulting in a trophectoderm cell-fate [3].
Collectively, these studies highlight the importance of Cdx2 in
repression of Oct4 expression in the developing trophectoderm.
While much has been learned about the sequence of
morphological and molecular events that lead up to segregation
of the ICM and trophectoderm lineages [2,4–7], less is known
about the epigenetic processes that facilitate Oct4 repression in the
blastocyst trophectoderm. Brahma related gene 1 (Brg1)-depen-
dent chromatin remodeling complexes represent a subclass of
SWItch/Sucrose NonFermentable (SWI/SNF) ATP-dependent
remodelers that play key roles in embryo development and cellular
differentiation [8–10]. In the nucleus Brg1 and Brg1 associated
factors (BAFs) are recruited to target gene promoters via tissue-
specific transcription factors to regulate transcription [11].
Previously, we identified an important role for Brg1 in blastocyst
development and ES cell pluripotency [9]. RNA interference
(RNAi)-mediated knockdown (KD) of Brg1 in early mouse
embryos results in developmental arrest at the blastocyst stage,
defects in the trophectoderm, and failure to repress Oct4 and
Nanog transcription [9]. Furthermore, utilizing genome-wide
location analysis we and others showed that Oct4 and Nanog
are direct targets of Brg1 in ES cells [9,12]. Consistent with these
findings Brg1 and BAF155 are required for the repression of
pluripotency genes in differentiating ES cells [13]. Altogether,
these findings suggest that Brg1 plays a critical role around the
blastocyst stage when the first cellular lineages are established.
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10622Here we report that Brg1 is an essential co-repressor required
for Cdx2-mediated silencing of Oct4 expression in the trophec-
toderm. We found that Brg1 and Cdx2 interact at the chromatin
level to repress Oct4 transcription in blastocysts. These findings
point to a novel role for Brg1 in transcriptional regulation of key
Cdx2 target genes in the developing trophectoderm to ensure
normal embryo development.
Results and Discussion
Brg1 regulates Oct4 expression in a stage-specific
manner during blastocyst formation
Recently, we detected higher amounts of Oct4 transcripts in
Brg1 depleted blastocysts compared to control blastocysts [9]. To
further assess the potential role of Brg1 in Oct4 regulation, we
examined the temporal and spatial expression of Oct4 during
blastocyst formation. In addition, we evaluated the expression of
the homeobox gene Cdx2, a negative regulator of Oct4
transcription in mouse blastocysts [2,3]. To accomplish this we
microinjected fertilized 1-cell embryos with Brg1 siRNA or control
siRNA and cultured them to the 8-cell, morula, and blastocyst
stages. The siRNAs utilized in this study are the same siRNAs
described previously [9]; they induce specific ablation of Brg1
transcripts in mouse embryos and phenocopy Brg1 null embryos
[8]. A combination of quantitative real-time PCR (qRT-PCR) and
immunocytochemistry (ICC) was used to examine the expression
of Oct4 and Cdx2. At the 8-cell and morula stages we did not
detect any differences in the expression or localization of Oct4 and
Cdx2 in Brg1 knockdown (KD) versus control embryos (Figure 1A
and B; p.0.05). In contrast, at the blastocyst stage, we observed a
significant increase in Oct4 mRNA (Figure 1A; p,0.05) and
widespread expression of Oct4 protein in Brg1 KD embryos versus
control embryos (Figure 1B). Interestingly, the levels of Cdx2
transcripts in Brg1 KD and control blastocysts were similar
(Figure 1A; p.0.05), suggesting that the Cdx2 gene itself is not a
transcriptional target of Brg1 in blastocysts.
To further explore the relationship between Brg1 and Oct4
transcription we microinjected various concentrations of Brg1
siRNA (0, 0.1, 1.0, 100 mM) into 1-cell embryos to generate a series
of day 4 blastocysts with different amounts of Brg1. We reasoned
that if Brg1 is a direct repressor of the Oct4 gene there should be a
dose dependency of Brg1 siRNA on Oct4 mRNA expression. qRT-
PCR was used to measure the levels of Brg1 and Oct4 transcripts in
Brg1 KD blastocysts. Interestingly, we observed an inverse
relationship between Brg1 levels and Oct4 expression (Figure 1C).
As the levels of Brg1 decreased there was a steady increase in Oct4
mRNA. Altogether, these findings indicate that Brg1 regulates Oct4
expression in a dose dependent manner and is critical for regulation
of Oct4 transcription at the blastocyst stage.
Brg1 KD blastocysts have normal levels of Cdx2 protein
and increased amounts of Oct4 protein in the
trophectoderm
Since Cdx2 is a direct repressor of Oct4 transcription in the
trophectoderm [3], we examined the precise expression and
localization of Cdx2 and Oct4 in Brg1 KD blastocysts. We
reasoned that changes in Cdx2 expression per se could be
accountable for misexpression of Oct4 in the trophectoderm.
Using confocal microscopy we calculated the average number of
Oct4+ (green), Cdx2+ (red), and Oct4 & Cdx2+ cells (yellow) in
control blastocysts and Brg1 KD blastocysts. In control blastocysts
Oct4 expression was restricted to cells in the ICM and was largely
absent in the Cdx2+ trophectoderm cells (Figure 2A a–d; Fig. S1).
In contrast, in Brg1 KD blastocysts Oct4 was widely expressed in
the Cdx2+ trophectoderm (Figure 2A e–h; Fig. S1). Remarkably,
there was no difference in the number of Cdx2+ cells (Figure 2B;
3061.6 vs. 3264.3; p.0.05) nor the total cell number (Figure 2B;
5362.0 vs. 5961.2; p.0.05) between Brg1 KD and control
blastocysts. On the other hand, there were approximately twice as
many Oct4+ cells in Brg1 KD blastocysts compared to control
blastocysts (Figure 2B; 3561.7 vs. 1861.9; p,0.05). Most
importantly, there were a higher number of cells that co-expressed
Oct4 and Cdx2 in Brg1 KD blastocysts versus control blastocysts
(Figure 2B; 2061.9 vs. 460.6; p,0.05). Collectively, these results
demonstrate that in Brg1 KD blastocysts Oct4 is widely expressed
in the trophectoderm and that this phenomenon is not caused by
alterations in Cdx2.
Brg1 cooperates with Cdx2 to repress Oct4 transcription
in blastocysts
The phenotype of Brg1 KD blastocysts resembled the
phenotype previously described for Cdx2 knockout blastocysts
[2]. Moreover, the phenotype of Brg1 KD blastocysts is similar to
Cdx2 KD blastocysts that were generated via microinjection of
Cdx2 siRNA into one-cell embryos (Figure S2). For example, both
Brg1 and Cdx2 KD embryos arrest around the blastocyst stage,
exhibit defects in the trophectoderm, and have increased
expression of Oct4 in the trophectoderm cells. Interestingly, in
Cdx2 KD blastocysts the levels of Brg1 mRNA and protein are
similar to control blastocysts further demonstrating that Brg1 and
Cdx2 do not regulate each other, but may act together to repress
Oct4 transcription (Figure S2). Thus, we hypothesized that Brg1
cooperates with Cdx2 to repress Oct4 transcription in the
trophectoderm.
To test this hypothesis we first examined the effect of combined
depletion of Brg1 and Cdx2 levels on Oct4 expression in
blastocysts. We predicted that loss of the Brg1-Cdx2 interaction
would de-repress Oct4 mRNA expression in blastocysts resulting
in higher levels of Oct4 transcripts. Accordingly, 1-cell embryos
were either microinjected with Brg1 siRNA (group 1), Cdx2
siRNA (group 2), Brg1 siRNA and Cdx2 siRNA (group 3), or
control siRNA (group 4) and cultured to the blastocyst stage.
Microinjection of Brg1 siRNA, Cdx2 siRNA, or a combination of
both induced a similar decrease in Brg1 and Cdx2 transcripts
(Figure S3). Microinjection of Brg1 siRNA or Cdx2 siRNA alone
resulted in a 2.160.2 and 2.360.5 fold increase in Oct4 mRNA
compared to control blastocysts, respectively (Figure 3A; p,0.05).
Remarkably, in Brg1 & Cdx2 double KD blastocysts we observed
a 4.360.4 fold increase in Oct4 mRNA compared to control
blastocysts (Figure 3A; p,0.05). This increase was significantly
greater than the levels of Oct4 in Brg1 KD and Cdx2 KD
blastocysts alone (Figure 3A; p,0.05). These results suggest that
Cdx2 and Brg1 may function additively to repress Oct4
transcription in blastocysts.
To determine whether Brg1 and Cdx2 associate during
trophectoderm development, three sets of experiments were
carried out. We first conducted co-immunoprecipitation assays
using mouse TS cells as a reference system for the blastocyst
trophectoderm. In these experiments, endogenous Brg1 was
recovered using a Brg1 rabbit anti-serum [14] and endogenous
Cdx2 recovery was measured by Western blot analysis. As shown
in Figure 3B, Cdx2 was indeed enriched in samples recovered
from the anti-Brg1 immunoprecipitation relative to reactions
performed using a rabbit IgG.
To further examine whether Brg1 and Cdx2 associate in the
trophectoderm confocal immunofluorescence analysis was carried
out in blastocysts using Brg1 and Cdx2 antibodies. This analysis
Brg1 and Oct4 Repression
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similar nuclear foci in trophectoderm cells (Figure 3C).
Lastly, we used chromatin-immunoprecipitation (ChIP) analysis
to determine whether Brg1 and Cdx2 are recruited to the Oct4
promoter during trophectoderm formation. To accomplish this we
utilized a doxycycline controllable Cdx2-inducible ES cell line as a
model system for the developing blastocyst trophectoderm [15];
these ES cells transdifferentiate into TS cells following induction of
Cdx2 expression. Previously, Rossant and co-workers demonstrat-
ed that Cdx2 is recruited to the ARE of the Oct4 promoter within
24 hours after induction of Cdx2 expression [3]. In preliminary
experiments we confirmed by Western blot and immunofluores-
cence analysis that Flag-Cdx2 was strongly induced at 24 hours
following removal doxycycline (Figure 3D). Moreover, at 24 to
48 hours after induction Oct4 expression was significantly down-
regulated in these cells (data not shown). Remarkably, ChIP
analysis revealed that both Brg1 and Cdx2 are recruited to the
Oct4 ARE at 24 hours following induction of Cdx2 expression
(Figure 3E; p,0.05). The recruitment of Brg1 and Cdx2 to the
ARE corresponded to when Oct4 became repressed in these cells.
Figure 1. Brg1 is required for repression of Oct4 expression at the blastocyst stage. (A) qRT-PCR analysis of Brg1, Cdx2, and Oct4
transcripts in Brg1 KD 8-cell embryos, morulae, and blastocysts. Data were normalized to Ubtf (house keeping gene) and are relative to control
embryos at each stage; black line=1. Asterisk denotes significant difference between Brg1 KD and control blastocysts (p,0.05). (B) ICC analysis of
Oct4 and Cdx2 expression in Brg1 KD 8-cell embryos, morulae, and blastocysts. Nuclei were counter stained with DAPI (blue). (C) Brg1 represses Oct4
expression in a dose dependent manner. One-cell embryos were injected with 0 mM (control), 0.1 mM, 1 mM, or 100 mM Brg1 siRNA and cultured to
the blastocyst stage. Real-time qPCR was used to analyze the levels of Brg1 and Oct4 transcripts. Data were normalized to Ubtf and are relative to
control blastocysts; dashed line=1.
doi:10.1371/journal.pone.0010622.g001
Brg1 and Oct4 Repression
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negative control intergenic region (Figure 3E; p.0.05). Collec-
tively, these results strongly suggest that Brg1 and Cdx2 cooperate
at the chromatin level to repress Oct4 transcription during
trophectoderm development.
Brg1-dependent repression of Oct4 expression does not
require DNA methylation
It has been established that Oct4 silencing in TS cells is
controlled by epigenetic modifications of chromatin, including
DNA methylation [16]. In some cellular contexts, Brg1 represses
transcription through recruitment of DNA methyltransferases
(DNMTs) to target gene promoters [17]. Thus, we hypothesized
that Brg1-mediated repression of the Oct4 expression in
blastocysts might involve epigenetic modification events. We
decided to test (1) whether the Oct4 gene is repressed via DNA
methylation at the blastocyst stage and (2) if disruption of Brg1
influences the methylation status of the Oct4 promoter. To
accomplish this we conducted bisulfite-sequencing analysis of
genomic regions within the Oct4 proximal enhancer (PE) and
proximal promoter (PP) in blastocysts, TS cells, and ES cells.
Accordingly, in ES cells the Oct4 PE and PP regions were largely
unmethylated consistent with the high levels of Oct4 expression in
these cells (Figure 4A I and II). In contrast, in TS cells where Oct4
expression is silenced, the Oct4 promoter was highly methylated in
both the PE and PP regions (Figure 4A I and II;P,0.05). We next
analyzed the methylation profiles of the trophectoderm of Brg1
KD blastocysts versus control blastocysts. To achieve this we
separated the trophectoderm from early blastocysts (day 4.0) and
late blastocysts (day 4.5) using laser-mediated dissection and
processed them for bisulfite sequencing. First, to confirm that our
assay was sensitive enough for smaller pools of embryos we
analyzed the differentially methylated region (DMR) of the
imprinted Snrpn gene. We found that this region was hemi-
methylated in these embryos (data not shown). Interestingly, in the
trophectoderm of control blastocysts, irrespective of the stage, the
Oct4 PE and PP regions were almost completely unmethylated
(Figure 4B). Moreover, in Brg1 KD embryos we did not observe
any changes in DNA methylation in the trophectoderm of early or
late blastocysts (Figure 4B). No differences in methylation were
observed between control blastocysts and Brg1 KD blastocysts
(p.0.05). Collectively, these results suggest that Brg1-mediated
repression of Oct4 in blastocysts does not require DNA
methylation and that other mechanisms are likely important for
facilitating Oct4 repression during blastocyst formation.
A model for Brg1/Cdx2-mediated repression of Oct4
expression in trophectoderm
We describe herein a novel role for Brg1 and Cdx2 in regulation
of Oct4 expression in blastocysts. To date little is known about the
repressive function of Brg1 during blastocyst formation and
establishment of the first cellular lineages. Moreover, the
underlying epigenetic processes responsible for Cdx2-mediated
repression of Oct4 in the trophectoderm are largely unknown.
Figure 2. Expression and localization of Cdx2 and Oct4 in Brg1 KD blastocysts. (A) ICC analysis of Oct4 and Cdx2 in Brg1 KD and control
blastocysts. In control blastocysts (a–d) Oct4 expression (green) is restricted to the ICM and is largely absent in the Cdx2-positive (red) trophectoderm.
In contrast, in Brg1 KD blastocysts (e–h) Oct4 is widely expressed in both the ICM and cdx2-positive (yellow) trophectoderm. Arrowheads denote co-
expression of Oct4 and Cdx2. Nuclei were counter stained with DAPI (blue). (B) Quantification of the average number of cells in Brg1 KD and control
blastocysts expressing Oct4, Cdx2, and Oct4 & Cdx2 (double expression). Asterisks denote statistical significance (p,0.05) between Brg1 KD and
control blastocysts. A total of 25 Brg1 KD blastocysts and 15 control blastocysts were analyzed.
doi:10.1371/journal.pone.0010622.g002
Brg1 and Oct4 Repression
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Brg1 is required for repression of Oct4 expression in the
trophectoderm, (II) Brg1 cooperates with Cdx2 to repress Oct4
transcription, and (III) Brg1 does not require DNMT activity to
repress Oct4 expression at the blastocyst stage. Therefore, we
propose a two-step model to explain the repression of Oct4
transcription in the blastocyst trophectoderm. Firstly, we predict
that Brg1 and Cdx2 are recruited to the ARE of the Oct4
promoter during blastocyst formation (Figure 5). This view is
supported by our findings in Cdx2-inducible ES cells where we
observed a significant enrichment of both Cdx2 and Brg1 at the
Oct4 promoter 24 hours after induction of Cdx2. The temporal
order in which Brg1 and Cdx2 are recruited to the Oct4 promoter
is currently not known. Notably, in some cell-types Brg1 is
recruited to target gene promoters via tissue-specific transcription
factors [11,14]. We envision that a similar mechanism may exist in
blastocysts. In future experiments we will determine whether the
recruitment of Brg1 to the ARE of the Oct4 promoter depends on
Cdx2.
Secondly, we theorize that once at the Oct4 promoter, Brg1 and
Cdx2 cooperate to facilitate chromatin remodeling and/or
targeting of other co-repressors to induce Oct4 repression
(Figure 5). In some cellular contexts Brg1 can associate with
HDACs and DNMTs to repress transcription [17,18]. In the
current study we addressed whether DNA methylation was
required for Brg1-dependent repression of Oct4 expression in
blastocysts. Interestingly, DNA methylation does not appear to be
required for the initial repression of Oct4 expression during
blastocyst formation. This finding is consistent with another study
that showed that the Nanog promoter is largely unmethylated in
blastocysts around the time Nanog becomes restricted to the ICM
[19]. Conversely, in TS cells Oct4 and Nanog silencing is tightly
Figure 4. Brg1-dependent repression of Oct4 expression in the trophectoderm does not require DNA methylation. (A I–II) Bisulfite
sequencing analysis of the Oct4 proximal enhancer (PE) and proximal promoter (PP) in ES cells and TS cells. Closed circles denote CpG methylation.
Asterisks denote statistical significance (p,0.05). (B) Bisulfite sequencing analysis of the Oct4 PE and PP in the trophectoderm of Brg1 KD blastocysts
and control blastocysts.
doi:10.1371/journal.pone.0010622.g004
Figure 3. Brg1 cooperates with Cdx2 to repress Oct4 transcription in blastocysts. (A) Combined depletion of Brg1 and Cdx2 augments
Oct4 expression in blastocysts. qRT-PCR analysis of Oct4 transcripts in Brg1 KD blastocysts, Cdx2 KD blastocysts, and Brg1 & Cdx2 double KD
blastocysts. Data were normalized to Ubtf (house keeping gene) and are relative to control blastocysts; dashed line=1. Different letters denote
statistical significance in Oct4 transcripts (p,0.05). These experiments were replicated using a total of 5 biological replicates. (B) Co-
immunoprecipitation and western blot analysis of Brg1 and Cdx2 in TS cells. Brg1 was immunoprecipitated using a rabbit anti-serum. Recovery of
Cdx2 was measured by western blot analysis. Cdx2 is enriched in the Brg1 IP samples and not in the control IgG samples. This assay was repeated a
total of 4 times using different batches of TS cells. (C) Confocal immunofluorescence analysis of Brg1 and Cdx2 in blastocysts. Co-localization of
endogenous Brg1 and Cdx2 in trophectoderm nuclei was determined using specific antibodies for Brg1 and Cdx2. Nuclei were counterstained with
DAPI. White box represents magnified region in bottom panel. Arrow denotes blastocyst ICM. (D) Confirmation of Flag-Cdx2 expression in induced ES
cells. Western blot and immunofluorescence analysis of Flag-Cdx2 expression at 24 hours following removal of doxycycline. (E) ChIP analysis of Brg1
and Cdx2 binding to the Oct4 promoter in Cdx2-inducible ES cells. qRT-PCR was used to determine the relative enrichment of Brg1 and Flag-Cdx2 at
the Oct4 ARE versus an intergenic region in uninduced and induced ES cell extracts. A non-specific rabbit IgG was included as a negative control.
Data were normalized to 1% input DNA. Asterisks denote significant differences between uninduced and induced samples (p,0.05). These
experiments were replicated 3 to 4 times using two different batches of Cdx2-inducible ES cell extracts.
doi:10.1371/journal.pone.0010622.g003
Brg1 and Oct4 Repression
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suggests that the silencing of Oct4 gene in the trophectoderm
lineage may be facilitated by a series of sequential epigenetic
modifications that initiate early on during blastocyst formation and
ensue during blastocyst development. We hypothesize that histone
modifications such as histone deacetylation are required for the
initial repression of Oct4 during blastocyst formation. In support
of this notion immunoprecipitation of Cdx2 in Cdx2-inducible ES
cell extracts resulted in a significant enrichment of HDAC1/2
[15]. Future studies will address whether Brg1 and/or Cdx2 are
necessary for the recruitment of HDAC1/2 to the Oct4 promoter
during the early stages of trophectoderm development.
In conclusion, Brg1 is obligatory for Cdx2-mediated repression
of Oct4 expression in blastocysts. It is likely that Brg1 is critical for
transcriptional regulation of other Cdx2 target genes in the
developing embryo. Our results provide a foundation for further
examination of these mechanisms.
Materials and Methods
Superovulation, embryo collection, microinjection,
embryo culture, and outgrowth analysis
B6D2/F1 female mice aged 6–8 weeks (Jackson Laboratory,
Bar Harbor, ME) were superovulated as previously described [9]
and mated with B6D2/F1 males. Fertilized one-cell embryos were
collected in M2 medium (Sigma-Aldrich, St. Louis, MO), washed,
and cultured in potassium simplex optimized medium (KSOM)
with amino acids (Specialty Media, Phillipsburg, NJ). Microinjec-
tions were carried out as described previously [21]. In brief, 5–
10 pL of 100 mM Brg1, Cdx2, or control siRNA (siGenome;
Dharmacon, Inc., Lafayette, CO) was injected into the cytoplasm
of one-cell embryos using a PL100 picoinjector (Harvard
Apparatus, Hollistan, MA). Following injection, embryos were
cultured in KSOM for 2 to 4 days depending on the experiment.
Outgrowth analysis was carried out on day 4 blastocysts by
removing zona pellucidae with acid Tyrode (Sigma-Aldrich),
washing in M2 medium, and culturing in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 15% fetal bovine
serum (FBS) and 1,000 U/ml of leukemia inhibitory factor (LIF).
After 96 hours the percentage of blastocysts that attached and
underwent outgrowth was calculated. All animals were treated in
accordance with Institution Animal Care and Use Committee
guidelines under current approved protocols at Michigan State
University.
Embryonic stem (ES) cell and trophoblast stem (TS) cell
culture
R1 ES cells were, obtained from American Type Culture
Collection (ATCC, Manassas, VA), were cultured on mitomycin-
treated mouse embryonic fibroblasts (MEFs) in medium contain-
ing high-glucose DMEM supplemented with fetal calf serum
(FCS), LIF, L-glutamine, nonessential amino acids, b-mercapto-
ethanol. Cdx2-inducible ES cells were kindly provided by Dr.
Minoru Ko [15]. These cells were cultured on mitomycin-treated
puromycin resistant MEFs in ES cell medium supplemented with
0.2 mg/ml of doxycycline and 1.0 mg/ml of puromycin. Prior to
Cdx2-induction cells were switched onto gelatin and cultured in
the presence of 1.5 mg/ml of puromycin for 3 days. Transgene
expression was induced by removal of doxycycline and was
verified by Western blot using a Flag antibody (F3165; Sigma-
Aldrich). Cdx2 expression was confirmed by immunocytochemis-
try using a Cdx2 antibody (CDX2-88; Biogenex, San Ramon,
CA). TS cells were derived from day 4 blastocysts as described by
Rossant and co-workers [22]. TS cells were cultured on
mitomycin-treated MEFs in RPMI medium containing fetal
bovine serum (FBS), sodium pyruvate, L-glutamine, b-mercapto-
ethanol, fibroblast growth factor 4(FGF4), and Heparin. Two to 3
days before harvesting for biochemical assays they were switched
onto gelatin coated plates, minimizing contamination by MEFs.
RNA isolation, cDNA synthesis, and real-time qPCR
analysis of preimplantation embyros
Brg1 KD and control embryos were transferred into a 1.5-mL
tube in ,1 mL of M2 medium and immediately stored at 280uC
until used. Total RNA was isolated using the PicoPure RNA
isolation Kit (Molecular Devices, Sunnyvale, CA). Prior to RNA
isolation, 2 ng of RNA encoding GFP was added to each sample
to act as a carrier. Isolated RNA was then subjected to a single
round of cDNA synthesis, and final volume was adjusted so that
1 mL was equivalent to an embryo. qRT-PCR analysis was carried
out as described previously [9] using TaqMan probes and an ABI
7500 thermocycler (Applied Biosystems, Foster City, CA). All
Figure 5. Model for Brg1/Cdx2-mediated repression of Oct4 expression in trophectoderm. Schematic diagram of Oct4 regulation in
blastocysts. In the trophectoderm Brg1 is recruited to the ARE of the Oct4 promoter via Cdx2. Once at the Oct4 promoter Brg1 and Cdx2 facilitate
recruitment of additional co-repressors to repress transcription.
doi:10.1371/journal.pone.0010622.g005
Brg1 and Oct4 Repression
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biological replicates.
Immunocytochemistry (ICC)
ICC analysis of preimplantation embryos and Cdx2-Inducible
ES cells was performed as previously described, with slight
modifications [9]. Briefly, embryos or stem cells were fixed,
permeabilized, washed, blocked, and incubated in a 1/100
dilution of antibodies for Oct4 (ab19857; abcam, Cambridge,
MA), Cdx2 (CDX2-88; Biogenex), or Brg1 [14] overnight at 4uC.
The following day embryos or stem cells were washed 3 times in
block solution. For secondary detection, samples were incubated in
a 1/1,000 dilution of Alexa Fluor 488 and 594 (Molecular Probes,
Eugene, OR), washed, mounted in Vectashield (Vector Labora-
tories, Burlingame, CA) containing 4,6-diamidino-2-phenylindole,
and imaged using a spinning disc confocal module (CARV; Atto
Bioscience, Rockville, MD) with Metamorph software.
Co-immunoprecipitation and Western blot analysis
For immunoprecipitation of Brg1, approximately 2 mg of TS
cell lysate (200 ml) was diluted to 500 ml in lysis buffer (50 mM
HEPES,150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 10%
glycerol, 0.1% tween 20) containing protease inhibitors and
incubated with 12 ml of Brg1 rabbit anti-serum [14] or equivalent
amount of rabbit IgG overnight at 4uC. Following overnight
incubation stable complexes were affinity purified by incubation
with 50 ml of Protein-G Fast Flow agarose beads (Millipore) for
4 hours at 4uC. Beads bound to immunoprecipitated complexes
were washed once in lysis buffer and twice in PBS. Bound proteins
were eluted from the beads by boiling in 2X Laemmli buffer and
size fractionated using 12.5% SDS-PAGE. CDX2 was detected by
Western blot analysis using an affinity purified rabbit anti-CDX2
antibody (A300-692A, Bethyl Laboratories, Inc). In order to avoid
intervening signal from immunoglobulin heavy and light chains,
HRP-conjugated Protein A (Zymed, Invitrogen, Carlsbad, CA)
was used for Western blot detection instead of HRP-conjugated
secondary antibody [23].
Chromatin-immunoprecipitation (ChIP) analysis
Cdx2-inducible ES cells were harvested and chemically cross-
linked with 1% formaldehyde (Sigma-Aldrich) for 19 hours at 4uC.
We previously determined that these fixation conditions work
excellent for Brg1 ChIP [9]. Cells were pelleted, washed with PBS
and flash frozen in liquid nitrogen. Pellets were resuspended in
ChIP lysis buffer. Cells were sonicated using a Branson Sonifier
450D (Branson, Danbury, CT, http://www.sonifer.com) at 50%
amplitude, with 6 1-minute pulses in ice water. Postsonication,
samples were centrifuged and flash frozen in liquid nitrogen.
Sonicated cell extracts equivalent to 2.5610
6 cells were used in
subsequent immunoprecipitations. Samples were precleared with
protein G Dynabeads (Dynal Biotech, Carlsbad, CA, http://www.
invitrogen.com/dynal) in 1 ml of dilution buffer. Cell extracts
were incubated overnight at 4uC with 5 mL of Brg1 rabbit anti-
serum [14], 2 mg of rabbit anti-Flag (F7425, Sigma-Aldrich), or
2 mg of rabbit non-specific IgG (Millipore). Chromatin antibody
complexes were isolated with 50 mL of protein G Dynabeads and
washed one time with low-salt buffer, one time with high-salt
buffer, one time with LiCl wash buffer, and twice with TE buffer.
Protein/DNA complexes were eluted from the beads at 65uC with
occasional vortexing. Crosslinking was reversed by addition of
NaCl and incubation overnight at 65uC. Extracts were then
treated with RNase A and proteinase K, and DNA was purified
using an Upstate EZ ChIP kit (Millipore). qRT-PCR was
performed on Brg1 ChIP DNA, Flag-Cdx2 ChIP DNA, Input
DNA and IgG control DNA using SYBR Green Master Mix
reagents with an ABI 7500 sequence detection system. The
following primer pair was used to analyze the Oct4 ARE region:
forward 59-TGAACTGTGGTGGAGAGTGC-39 and reverse 59-
AGGAAGGGCTAGGACGAGAG-39. Negative control primers
for an intergenic region were the following: forward 59-
TTTTCAGTTCACACATATAAAGCAGA-39 and reverse 59-
TGTTGTTGTTGTTGCTTCACTG-39.
Bisulfite-sequencing analysis of DNA methylation
The trophectoderm of day 4 and day 4.5 blastocysts (control
and Brg1 KD) was isolated by laser dissection using a 40X laser
objective lens and controller (Hamilton Throne Bioscience,
Beverly, MA). A total of 10 to 15 isolated trophectoderm from
each time point were pooled (,400 cells), and stored at 280uC for
future use. A total of 5 to 7 ES cell or TS cell colonies were
isolated, and stored at 280uC. Extraction of genomic DNA and
bisulfite mutagenesis sequencing analysis were conducted using the
ReadyAmp Genomic Kit (Promega, Madison, WI) and the EZ
DNA Methylation Kit (Zymo Research, Orange, CA), respective-
ly, according to the manufacturer’s instructions. After bisulfite
mutation, DNA was eluted in 20 mL of elution buffer, and
subjected 2 successive rounds of PCR amplification (35 cycles
each) using primer pairs for the Oct4 Promoter. For the proximal
enhancer we used the following outer and inner primer pairs:
outer forward primer, 59-TTTGTAGATAGGTATTTT-
GAGGGT-39 and outer reverse primer, 59-ACAAAACTTCCC-
CAACTCTCCACC-39; inner forward primer, 59-GGGATTTT-
TAGATTGGGTTTAGAAA-39 and inner reverse primer, 59-
CTCCTCAAAAACAAAACCTCAAATA-39. For the proximal
promoter we used an outer forward primer, 59-GGTTTTTA-
GGTGGGTTTGGAATC-39 and outer reverse primer, 59-CA-
ACCAAATCCCTTCACTTACCT-39; inner forward primer, 59-
AGAGGTATTGGGGATTTTTTTATGT-39 and inner reverse
primer, 95-AAAATTAATTCCACCTTCTCCAACT-39. PCR
products were verified by running on a 2% agarose gel. Then,
PCR products were ligated into the pTOPO 10 vector system
(Invitrogen) and 10 to 12 clones were randomly picked for
sequencing. A total of two biological replicates were analyzed.
Statistical analysis
Data from qRT-PCR and DNA methylation experiments were
analyzed by SAS software (version 9.0, SAS Institute Inc., Cary,
NC). A student’s t-test was used to determine statistical differences
between groups. A p-value of ,0.05 was considered significant.
Supporting Information
Figure S1 Expression and localization of Cdx2 and Oct4 in
Brg1 KD and control blastocysts. (A) In control blastocysts Oct4
expression (green) is restricted to the ICM and is largely absent in
the Cdx2-positive (red) trophectoderm. (B) In Brg1 KD blastocysts
Oct4 (green) is widely expressed in both the ICM and cdx2-
positive (red) trophectoderm. Double Oct4 & Cdx2 positive cells
are shown in yellow. Blastocysts were counterstained with DAPI to
visualize nuclei.
Found at: doi:10.1371/journal.pone.0010622.s001 (2.26 MB
TIF)
Figure S2 Phenotypic analysis of Brg1 KD and Cdx2 KD
blastocysts. (A) Summary of preimplantation development. Results
represent the average 6 SEM from 3 experiments. A total of 60
control embryos, 53 Cdx2 KD embryos, and 48 Brg1 KD
embryos were examined. Black bars, one-cell embryos injected
with control siRNA; white bars, one-cell embryos injected with
Brg1 and Oct4 Repression
PLoS ONE | www.plosone.org 8 May 2010 | Volume 5 | Issue 5 | e10622Cdx2 siRNA; gray bars, one-cell embryos injected with Brg1
siRNA. (B) Percentage of control embryos, Brg1 KD embryos and
Cdx2 KD embryos hatching on day 4. (C) Micrographs of control
blastocysts, Brg1 KD blastocysts, and Cdx2 KD blastocysts on
days 4 and 5, and after 96hrs of outgrowth. Arrows indicate
hatching embryos. Arrowheads highlight trophectoderm cells, and
dotted lines indicate the boundary of trophectoderm outgrowth.
(D) ICC analysis of Oct4 expression in control blastocysts, Brg1
KD blastocysts, and Cdx2 KD blastocysts. Blastocysts were co-
stained with DAPI to visualize nuclei. (E) ICC and qRT-PCR
analysis of Brg1 and Oct4 expresssion in Cdx2 KD blastocysts and
control blastocysts. Blastocysts were co-stained with DAPI to
visualize nuclei. qRT-PCR data were normalized to Ubtf (house
keeping gene) and are relative to control blastocysts.
Found at: doi:10.1371/journal.pone.0010622.s002 (1.93 MB TIF)
Figure S3 Real-time PCR analysis of Brg1 and Cdx2 transcripts
in embryos microinjected with Brg1 and Cdx2 siRNA. (A)
Microinjection of Brg1 siRNA or Brg1 siRNA and Cdx2 siRNA
combined triggers a similar reduction in Brg1 transcripts in
preimplantation embryos. (B) Microinjection of Cdx2 siRNA or
Cdx2 siRNA and Brg1 siRNA combined induces a similar
reduction in Cdx2 transcripts in preimplantation embryos. Data
were normalized to Ubtf (house keeping gene) and are relative to
control blastocysts. Different letters denote statistical significance
(p,0.05).
Found at: doi:10.1371/journal.pone.0010622.s003 (1.08 MB TIF)
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